Screening for colorectal neoplasia

Affiliations

Comment

O Kronborg. Ital J Gastroenterol Hepatol. 1999 Mar.

. 1999 Mar;31(2):127-9.

¹ Department of Surgery, Odense University Hospital, Denmark. Kronborg@med.ou.dk

No abstract available

Comment on

Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F, Sonnenberg A. Delcò F, et al. Ital J Gastroenterol Hepatol. 1999 Mar;31(2):119-26. Ital J Gastroenterol Hepatol. 1999. PMID: 10363196

[New criteria for detecting occult hemorrhage in screening for colorectal cancer].
Ottó S. Ottó S. Orv Hetil. 2001 Jul 22;142(29):1541-5. Orv Hetil. 2001. PMID: 11494745 Review. Hungarian.
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Fletcher RH, Ransohoff DF, Imperiale TF. Fletcher RH, et al. Cancer. 2007 May 1;109(9):1925-6; author reply 1926. doi: 10.1002/cncr.22611. Cancer. 2007. PMID: 17370313 No abstract available.
The effect of fecal occult-blood screening on the incidence of colorectal cancer.
Allison JE. Allison JE. N Engl J Med. 2001 Mar 29;344(13):1022; author reply 1023. N Engl J Med. 2001. PMID: 11280326 No abstract available.
Fecal occult blood testing options.
Lastella VP. Lastella VP. Gastroenterology. 2006 Jan;130(1):285; author reply 285. doi: 10.1053/j.gastro.2005.11.039. Gastroenterology. 2006. PMID: 16401498 No abstract available.
[Colorectal cancer screening should be evaluated in Swedish studies].
Blom J. Blom J. Lakartidningen. 2008 Sep 17-23;105(38):2564-7. Lakartidningen. 2008. PMID: 18846858 Review. Swedish. No abstract available.